INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
138 hedge funds and large institutions have $383M invested in Insys Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 40 increasing their positions, 44 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
+14
Holders Change %
+11.29%
% of All Funds
3.69%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
29
Increased
40
Reduced
44
Closed
15
Calls
$4.89M
Puts
$5.95M
Net Calls
-$1.05M
Net Calls Change
+$9.65M
Top Buyers
| 1 |
O
OrbiMed
New York
|
$64.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$4.57M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
$4.33M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
$2.4M |
| 5 |
State Street
Boston,
Massachusetts
|
$14.5M |
